Pharmaceuticals stocks with healthy balance sheets, growth and ROCE
| Company | CMP (Rs) | RoCE (Latest, %) | D/E (Curr FY, x) | EBITDA (3 yrs, %) | EBITDA | RoE (Latest, %) | Sales (Rs m) |
|---|---|---|---|---|---|---|---|
| GSK PHARMA | 2,484.7 | 64.1% | 0.0 | 15.6% | 11,773.6 | 47.2% | 37,492 |
| ABBOTT INDIA | 26,661.5 | 45.2% | 0.0 | 16.1% | 16,921.3 | 33.6% | 64,092 |
| TORRENT PHARMA | 4,380.4 | 33.3% | 0.4 | 15.1% | 37,043.5 | 25.2% | 115,161 |
| NATCO PHARMA | 1,174.0 | 30.4% | 0.0 | 102.7% | 21,938.0 | 24.8% | 44,295 |
| J.B.CHEMICALS | 2,151.9 | 27.5% | 0.0 | 23.9% | 10,311.2 | 20.2% | 39,180 |
| CADILA HEALTHCARE | 938.9 | 26.0% | 0.1 | 29.5% | 68,935.0 | 19.3% | 232,415 |
| DR. REDDYS LAB | 1,293.3 | 23.3% | 0.1 | 31.4% | 85,471.0 | 17.1% | 326,439 |
| CIPLA | 1,347.7 | 22.1% | 0.0 | 16.5% | 71,279.0 | 17.0% | 275,476 |
| NEULAND LABS | 17,693.7 | 22.0% | 0.1 | 31.4% | 3,232.6 | 17.1% | 14,768 |
| ASTRAZENECA PHARMA | 8,489.3 | 20.7% | 0.0 | 43.4% | 2,539.7 | 15.2% | 17,163 |
| NARAYANA HRUDAYALAYA | 1,819.8 | 19.6% | 0.6 | 24.9% | 12,933.7 | 21.8% | 54,830 |
| SUN PHARMA | 1,847.3 | 19.4% | 0.0 | 15.1% | 150,862.0 | 15.2% | 525,784 |
| DISHMAN PHARMA | 1,287.7 | 17.5% | 0.6 | 12.2% | 4,103.2 | 11.8% | 15,898 |
| AMI ORGANICS | 2,733.2 | 17.0% | 0.0 | 30.2% | 2,320.7 | 12.3% | 10,069 |
* We show NM where the values are negative
Disclaimer: This is for information purposes only. These are not stock recommendations and should not be treated as such. Learn more about our recommendation services here... Also note that these screeners are based only on numbers. There is no screening for management quality.